| Aug 23, 2022 |
2022 FC 1218 |
Janssen v. Pharmascience
We successfully represented Janssen in defending the validity of the patent relating to Janssen’s INVEGA SUSTENNA® (paliperidone palmitat...
|
Patents
|
|
| Jan 31, 2022 |
2022 FC 107 |
Janssen v Apotex
We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Apotex in respect of Janssen’s ...
|
Patents
|
|
| Jan 19, 2022 |
2022 FC 62 |
Janssen v Pharmascience
We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Pharmascience in respect of Janssen&r...
|
Patents
|
|
| Jul 28, 2021 |
2021 FCA 154 |
Seedlings v. Pfizer
We successfully represented Pfizer on this appeal related to a mechanical device patent and Pfizer’s epinephrine auto injector product EpiPen...
|
Patents
|
|
| Mar 4, 2021 |
2021 FCA 45 |
Apotex v. Janssen
We successfully represented Janssen on this appeal. The Federal Court of Appeal upheld the trial judge’s decision that the patent was valid a...
|
Patents
|
|
| Jan 14, 2021 |
2021 FCA 4 |
Elea v Simplot
We successfully represented Elea on this appeal. J.R Simplot, the defendant in a patent infringement action brought by McCain, had issued a third p...
|
Patents
|
|
| Jan 14, 2021 |
2021 FC 7 |
Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories
We represented Janssen and BTG in these patent infringement actions relating to Janssen’s prostate cancer product ZYTIGA®(abiraterone ace...
|
Patents
|
|
| May 5, 2020 |
2020 FC 593 |
Janssen Inc. et al v Teva Canada Limited
We successfully represented Janssen in this patent infringement action under the new PMNOC Regulations concerning Janssen’s Invega Sustenna (...
|
Patents
|
|
| Jan 2, 2020 |
2020 FC 1 |
Seedlings Life Sciences v Pfizer
We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...
|
Patents
|
|
| Oct 29, 2019 |
2019 FC 1355 |
Janssen Inc. et al v Apotex Inc.
We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” applica...
|
Patents
|
|
| Jul 13, 2018 |
2018 FC 736 |
Eli Lilly Canada Inc. et al v. Apotex Inc.
We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.
|
Patents
|
|
| Apr 10, 2018 |
Federal Court File Nos. T-598-17 through T-605-17 |
AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA. The c...
|
Patents
|
|
| Apr 9, 2018 |
Federal Court File No. T-1355-17 |
Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...
|
Patents
|
|
| Feb 8, 2018 |
2018 FCA 33 |
Teva Canada Limited v. Janssen Inc.
We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...
|
Patents
|
|
| Feb 6, 2018 |
2018 FCA 32 |
Apotex Inc. v. Bayer Inc.
We successfully represented Bayer Inc. on this appeal, which upheld the patentee’s right to elect its damages.
|
Patents
|
|
| Dec 9, 2016 |
2016 FC 1361 |
Janssen Inc. et al. v. Actavis Pharma Company et al.
We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA. The generic company Actavis Pharma had challen...
|
Patents
|
|
| Nov 18, 2016 |
2016 ONSC 7151 |
Actavis Pharma Company v Alcon Canada Inc. et al.
We obtained an order dismissing Actavis’ claims for monetary relief under the UK and Ontario Statutes of Monopolies, in an action for damage...
|
Patents
|
|
| Sep 9, 2016 |
2016 FC 1013 |
Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company
We successfully represented Bayer in this patent infringement action. Following a six week trial, the Federal Court agreed that Bayer’s paten...
|
Patents
|
|
| May 31, 2016 |
2016 FCA 161 |
Pfizer Canada Inc. v. Teva Canada Limited
We successfully represented Pfizer in this appeal from an award of section 8 damages in excess of $100 million in relation to a patent on EFFEXOR. ...
|
Patents
|
|
| May 31, 2016 |
2016 FC 593 |
Janssen Inc. v. Teva Canada Limited
We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....
|
Patents
|
|
| May 27, 2016 |
2016 FC 581 |
Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.
We obtained an order preventing Fresenius from obtaining approval to market a generic version of Bayer’s AVELOX IV product until expiry of Bayer’s patent.
|
Patents
|
|
| Sep 16, 2015 |
2015 FCA 192 |
Actavis Pharma Company v. Alcon Canada Inc.
We successfully represented Alcon and Bayer in this appeal brought by Actavis. The Federal Court had upheld the validity of Bayer’s patent re...
|
Patents
|
|
| Aug 31, 2015 |
Court File No. T-2247-14 |
Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc.
We successfully represented Eli Lilly in a patent proceeding relating to Eli Lilly’s diabetes medicine BASAGLAR. After filing a motion to dis...
|
Patents
|
|
| May 4, 2015 |
2015 FCA 116 |
Cobalt Pharmaceuticals Company v. Bayer Inc.
We successfully represented Bayer in appeals from a decision of the Federal Court regarding patents covering oral contraceptives containing drospir...
|
Patents
|
|
| Oct 28, 2014 |
2014 FCA 242 |
Janssen Inc. v. Abbvie Corporation
We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading. The Court of Appeal agre...
|
Patents
|
|
| Oct 1, 2014 |
Court File No. A-45-14 |
Takeda v. Apotex
We represented Takeda on appeals from a section 8 damages action relating to pantoprozole (PANTOLOC®). The appeals were resolved prior to a hea...
|
Patents
|
|
| May 14, 2014 |
2014 FC 462 |
Alcon Canada Inc. v. Cobalt Pharmaceuticals Company
We successfully defended the validity of Bayer’s patent covering the antibiotic moxifloxacin (AVELOX® and VIGAMOX ®) and obtaine...
|
Patents
|
|
| May 7, 2014 |
2014 FC 436 |
Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health
We represented Bayer in this application under the PMNOC Regulations. The validity of Bayer’s patent covering the oral contraceptives YASMIN&...
|
Patents
|
|
| Apr 3, 2014 |
2014 FC 248 |
Teva Canada Limited v. Pfizer Canada Inc.
We represented Pfizer in defending a damages case pursuant to section 8 of the PMNOC Regulations.
|
Patents
|
|
| Feb 14, 2014 |
2014 FC 149 |
Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149
We represented Alcon in this application under the PMNOC Regulations relating to Cobalt’s generic version of an olopatadine eye drop solution.
|
Patents
|
|
| Dec 11, 2013 |
2013 FC 1237 |
Apotex Inc. v. Takeda Canada Inc.
We represented Takeda in defending a damages case pursuant to section 8 of the PMNOC Regulations.
|
Patents
|
|
| Oct 22, 2013 |
2013 FC 1061 |
Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Cobalt Pharmaceuticals Company and the Minister of Health
We represented Bayer and obtained a prohibition order against Cobalt’s generic version of Bayer’s YAZ® (drospirenone / ethinyl estr...
|
Patents
|
|
| Aug 12, 2013 |
2013 FC 750 |
Varco Canada Limited v. Pason Systems Corp.
Peter Wilcox acted for National Oilwell Varco as lead counsel in a patent infringement and validity trial related to automatic drilling equipment f...
|
Patents
|
|
| Apr 11, 2012 |
2012 FC 410 |
Alcon Canada Inc. v. Apotex Inc.
We represented Alcon in a proceeding under the PMNOC Regulations relating to PATANOL.
|
Patents
|
|
| Mar 11, 2011 |
2011 FC 239 |
GlaxoSmithKline Inc. v. Pharmascience Inc.
Peter Wilcox successfully acted for GlaxoSmithKline in a proceeding in which attacks on the validity of the patent covering GSK’s diabetes me...
|
Patents
|
|
| Jul 12, 2010 |
2010 FC 741 |
Nicholas v. Environmental Systems (International) Limited
Peter Wilcox acted for Environmental Systems (International) and Reif Estate Wineries at trial in the successful defence of a $27 million copyright...
|
Copyright
|
|
| May 12, 2010 |
2010 FC 42 |
Janssen-Ortho Inc. v. Canada (Health)
We represented Janssen-Ortho and Alza Corporation in a proceeding under the PMNOC Regulations relating to CONCERTA®.
|
Patents
|
|
| Apr 14, 2010 |
2010 FC 409 |
Pfizer Canada Inc. v. Novopharm Limited
Peter Wilcox acted for Pfizer in various proceedings relating to pregabalin (LYRICA®).
|
Patents
|
|
| Jun 26, 2009 |
2009 FC 671 |
Pfizer Canada Inc. v. Apotex Inc.
Peter Wilcox acted for Pfizer in a proceeding related to amlodipine (NORVASC®), including successfully resisting a motion to dismiss.
|
Patents
|
|
| Nov 6, 2008 |
2008 SCC 61 |
Apotex Inc. v. Sanofi-Synthelabo Canada Inc.
Peter Wilcox acted for BIOTECanada, an intervener in the Supreme Court of Canada. BIOTECanada supported the successful respondent Sanofi in t...
|
Patents
|
|
| Oct 24, 2008 |
2008 FC 1195 |
Lotech Medical Systems Limited v. Kinetic Concepts Inc.
Peter Wilcox acted for Kinetic Concepts in a patent infringement and validity action related to therapeutic mattresses.
|
Patents
|
|
| Mar 20, 2008 |
2008 FCA 108 |
Pfizer Canada Inc. v. Canada (Health) - 2008 FCA 108
Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...
|
Patents
|
|
| Oct 5, 2007 |
2007 FC 898 |
Pfizer Canada Inc. v. Canada (Health) - 2007 FC 898
Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...
|
Patents
|
|
| Jun 18, 2007 |
2007 FC 649 |
Pfizer Canada Inc. v. Canada (Health) - 2007 FC 649
Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...
|
Patents
|
|
| Dec 7, 2006 |
2006 FC 1471 |
Pfizer Canada Inc. v. Canada (Minister of Health)
Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (Lipitor) against various gen...
|
Patents
|
|